University of California, Los Angeles: Sclerosis trials
The registry lists 12 Sclerosis studies with University of California, Los Angeles as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 5Phase 2 9Phase 4 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With AmbrisentanCompletedNCT01051960Phase 4Results posted
- Locomotor Training in Persons With Multiple SclerosisCompletedNCT00607126Phase 1/2Results posted
- A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic SclerosisCompletedNCT00512902Phase 1/2Results posted
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT00451204Phase 2Results posted
- Testosterone Treatment for Multiple SclerosisCompletedNCT00405353Phase 1/2Results posted
- Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy SurgeryWithdrawnNCT04344626Not applicable
- JASPER Early Intervention for Tuberous SclerosisStatus unknownNCT03422367Not applicable
- Testosterone for Fatigue in Men With MSWithdrawnNCT03000127Phase 2
- A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple SclerosisWithdrawnNCT02317263Phase 2
- Estriol Treatment in Multiple Sclerosis (MS): Effect on CognitionStatus unknownNCT01466114Phase 2
- Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple SclerosisCompletedNCT01219647Phase 1/2
- Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2